Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-04-19
2011-04-19
Vivlemore, Tracy (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S024500
Reexamination Certificate
active
07928083
ABSTRACT:
The invention relates to the treatment of rheumatoid arthritis, particularly to the use of nucleic acid agents capable of silencing H19 for the treatment of rheumatoid arthritis. The invention provides methods for ameliorating rheumatoid arthritis and symptoms associated therewith, utilizing gene silencing oligonucleotides such as small interfering RNA (siRNA) agents directed to H19.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan, Jr. et al.
patent: 3791932 (1974-02-01), Schuurs et al.
patent: 3839153 (1974-10-01), Schuur et al.
patent: 3850578 (1974-11-01), McConnell
patent: 3850752 (1974-11-01), Schuur et al.
patent: 3853987 (1974-12-01), Dreyer
patent: 3867517 (1975-02-01), Ling
patent: 3879262 (1975-04-01), Schuur et al.
patent: 3901654 (1975-08-01), Gross
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 3984533 (1976-10-01), Uzgiris
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4034074 (1977-07-01), Miles
patent: 4098876 (1978-07-01), Piasio et al.
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4476301 (1984-10-01), Imbach et al.
patent: 4666828 (1987-05-01), Gusella
patent: 4683202 (1987-07-01), Mullis
patent: 4801531 (1989-01-01), Frossard
patent: 4873316 (1989-10-01), Meade et al.
patent: 4879219 (1989-11-01), Wands et al.
patent: 5011771 (1991-04-01), Bellet et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5166315 (1992-11-01), Summerton et al.
patent: 5177196 (1993-01-01), Meyer, Jr. et al.
patent: 5185444 (1993-02-01), Summerton et al.
patent: 5188897 (1993-02-01), Suhadolnik et al.
patent: 5192659 (1993-03-01), Simons
patent: 5214134 (1993-05-01), Weis et al.
patent: 5216141 (1993-06-01), Benner
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5264562 (1993-11-01), Matteucci
patent: 5264564 (1993-11-01), Matteucci
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5278302 (1994-01-01), Caruthers et al.
patent: 5281521 (1994-01-01), Trojanowski
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5321131 (1994-06-01), Agrawal et al.
patent: 5399676 (1995-03-01), Froehler
patent: 5405938 (1995-04-01), Summerton et al.
patent: 5405939 (1995-04-01), Suhadolnik et al.
patent: 5434257 (1995-07-01), Matteucci et al.
patent: 5453496 (1995-09-01), Caruthers et al.
patent: 5455233 (1995-10-01), Spielvogel et al.
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5466677 (1995-11-01), Baxter et al.
patent: 5470967 (1995-11-01), Huie et al.
patent: 5476925 (1995-12-01), Letsinger et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5489677 (1996-02-01), Sanghvi et al.
patent: 5519126 (1996-05-01), Hecht
patent: 5536821 (1996-07-01), Agrawal et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5541306 (1996-07-01), Agrawal et al.
patent: 5541307 (1996-07-01), Cook et al.
patent: 5550111 (1996-08-01), Suhadolnik et al.
patent: 5561225 (1996-10-01), Maddry et al.
patent: 5563253 (1996-10-01), Agrawal et al.
patent: 5571799 (1996-11-01), Tkachuk et al.
patent: 5587361 (1996-12-01), Cook et al.
patent: 5596086 (1997-01-01), Matteucci et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 5608046 (1997-03-01), Cook et al.
patent: 5610289 (1997-03-01), Cook et al.
patent: 5618704 (1997-04-01), Sanghvi et al.
patent: 5623070 (1997-04-01), Cook et al.
patent: 5625050 (1997-04-01), Beaton et al.
patent: 5633360 (1997-05-01), Bischofberger et al.
patent: 5663312 (1997-09-01), Chaturvedula
patent: 5677437 (1997-10-01), Teng et al.
patent: 5677439 (1997-10-01), Weis et al.
patent: 5714331 (1998-02-01), Buchardt et al.
patent: 5719262 (1998-02-01), Buchardt et al.
patent: 5721138 (1998-02-01), Lawn
patent: 5955273 (1999-09-01), Hochberg et al.
patent: 6303374 (2001-10-01), Zhang et al.
patent: 6326174 (2001-12-01), Joyce et al.
patent: 7041654 (2006-05-01), Hochberg et al.
patent: 2002/0123476 (2002-09-01), Emanuele et al.
patent: 2002/0128218 (2002-09-01), Emanuele et al.
patent: 2003/0014372 (2003-01-01), Wheeler et al.
patent: 2003/0017068 (2003-01-01), Larrain et al.
patent: 2003/0096980 (2003-05-01), Froehler et al.
patent: 2003/0143732 (2003-07-01), Fosnaugh et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2005/0118625 (2005-06-01), Mounts
patent: 375408 (1990-06-01), None
patent: 264166 (1998-04-01), None
patent: WO 9524503 (1995-09-01), None
patent: WO 98/34613 (1998-08-01), None
patent: WO 00/71707 (2000-11-01), None
patent: 2004/031359 (2004-04-01), None
patent: WO 2004003159 (2004-04-01), None
patent: WO 2006119266 (2006-11-01), None
International Search Report Appln. No. PCT/IL06/00785.
International Search Report Appln. No. PCT/IL08/00072.
International Search Report Appln. No. PCT/IL08/00071.
U.S. Appl. No. 12/523,298, filed Jul. 15, 2009.
U.S. Appl. No. 12/015,325, filed Jan. 16, 2008.
U.S. Appl. No. 11/994,810, filed Jul. 8, 2008.
Ariel et al., 1994, Gynecol Oncol 53, 212-219.
Ariel et al., 2004, Mol Carcinog 41, 69-76.
Ayesh and Matouk et al., 2002, Mol Carcinog 35, 63-74.
Ayesh and Matouk et al., 2003, Mol Ther 7, 535-541.
Banerji et al., 1983, Cell 33, 729-740.
Beal, P. A. and Dervan, P.B., et al., 1991, Science 251, 1360-1363.
Bernstein et al., 2001, Nature 409, 363-366.
N. Berteaux et al, “H19 mRNA-like non-coding RNA promotes breast cancer cell proliferation through positive control by E2F1”, The Journal of Biological Chemistry, vol. 280, No. 33 Papers in Press, pp. 29625-29636 (2005).
Besch et al., 2002, J Biol Chem 277, 32473-79.
Blythe, N.L. et al., 1996, J Anat 188( Pt 1), 65-74.
Brannan et al., 1990, Mol Cell Biol 10, 28-36.
Brantl, 2002, Biochem Biophys Act 1575, 15-25.
Breaker, R.R. and Joyce G., 1995, Chemistry and Biology 2, 655-660.
Byrne et al., 1989, Proc Natl Acad Sci USA 86, 5473-5477.
Calame et al., 1988, Adv. Immunol. 43, 235-275.
Carbone, et al., 2003, Nucl Acid Res 31, 833-43.
Cooney, M. et al., 1988 Science 241, 456-459.
Cullen, 2002, Nat Immunol 3, 597-599.
Edlund et al., 1985, Science 230, 912-916.
Gilboa et al., 1986, Biotechniques 4(6), 504-512.
Graveel et al, 2001, Oncogene 20, 2704-2712.
Hammond et al., 2001, Nat Rev Gen 2, 110-119.
Hutvagner and Zamore, 2002, Curr Opin Genetics and Development 12, 225-232.
Kaplan, R., et al., 2003, Cancer Res 63, 1475-1482.
Khachigian, L.M., 2002, Curr Opin Mol Ther 4, 119-21.
Liang, C.Y., et al., 2004, Arch Virol 149, 51-60.
Lottin et al, 2002, Carcinogesis 23, 1885-1895.
Lottin et al, 2002, Oncogene 21, 1625-1631.
Maher III, L. J., et al., 1989, Science 245, 725-730.
Matouk et al., 2005, Cancer Therapy 3, 249-266.
Matouk et al., 2006, Hepatology 44(4 Supp. 1), 529A.
Matouk et al., 2007, PLoS ONE 2(9), e845.
Moser, H.E., et al., 1987, Science 238, 645-650.
Pinkert et al., 1987, Genes Dev 1, 268-277.
Puri et al., 2001, J Biol Chem 276, 28991-98.
Rachmilewitz et al, 1995, Oncogene 11, 863-870.
Rodesch et al, 1992, Obstet Gynecol 80, 283-285.
Santoro, S.W. & Joyce, G.F., 1997, Proc Natl Acad Sci USA 94, 4262-4266.
Seidman and Glazer, 2003, J Clin Invest 112, 487-94.
Sharp, 2001, Genes Dev 15, 485-90.
Soreq et al., 1974, J Mol Bio 88, 233-45.
Stuhlmuller et al, 2003, Am J Pathol 163, 901-911.
Tonkinson et al., 1996, Cancer Investigation 14(1), 54-65.
Tuschl, 2001, ChemBiochem 2, 239-245.
Vasquez et al., 1999, Nucl Acids Res 27, 1176-81.
Vuyisich and Beal, 2000, Nuc Acids Res 28, 2369-74.
Welch et al., 1998, Clin Diagn Virol 10, 163-71.
Welch et al., 1998, Cuff Opin Biotechnol 9, 486-96.
Winoto et al., 1989, EMBO J 8, 729-733.
Zabala, M. et al., 2004, Cancer Res 64(8), 2799-804.
Vivlemore Tracy
Winston & Strawn LLP
Yissum Research Development Company of the Hebrew University of
LandOfFree
H19 silencing nucleic acid agents for treating rheumatoid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with H19 silencing nucleic acid agents for treating rheumatoid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and H19 silencing nucleic acid agents for treating rheumatoid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631132